Trial intelligence / Profile preview

Esomeprazole acid control and healing in erosive esophagitis

NCT00206180Phase 4Completed

Sponsor
AstraZeneca
Start
Jun 2004
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of esomeprazole in erosive esophagitis (EE), sponsored by AstraZeneca. Started Jun 2004; status: completed.

02

Drugs

esomeprazole
03

Conditions

erosive esophagitis (EE)

Beyond the preview

Go deeper on NCT00206180.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00206180.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call